Are you Dr. Mott?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 63 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Frank Mott, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Medical College of GA at GRU.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1991 - 1994- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1991
Texas A&M; Health Science Center College of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1980 - 2025
OK State Medical License 2020 - 2021
LA State Medical License 2010 - 2017
GA State Medical License 2013 - 2017
WI State Medical License 1989 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
Publications & Presentations
PubMed
- Perception of subjective lived experiences of individuals with anorexia-cachexia in patients with advanced lung cancer.Yennurajalingam, S., Lu, Z., Urbauer, D., Stanton, P., Torres, H., Davis, S., Mott, F., Rantanen, P., Dev, R., Hui, D., Bruera, E.> ;Asia-Pacific Journal of Oncology Nursing. 2023 Nov 1
- Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancer.Eric K Singhi, Frank Mott, Michelle Worst, Cheuk Hong Leung, J Jack Lee, Brett Carter, Carolyn J Presley, John V Heymach, Mehmet Altan> ;Oncology Letters. 2023 Jun 1
- 1 citationsSafety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.Mehmet Altan, Janet Tu, Denái R Milton, Bulent Yilmaz, Yanyan Tian, Frank V Fossella, Frank E Mott, George R Blumenschein, Bettzy Stephen, Daniel D Karp, Funda Meric-B...> ;Cancer. 2023 Sep 1
- Join now to see all
Press Mentions
Nasopharyngeal Carcinoma Survivor: My Journey to Becoming an OncologistAugust 17th, 2020
Optimal Sequencing and Patient Selection Investigated in NSCLCDecember 4th, 2017
OncLive® to Host State of the Science Summit™ on Advanced Non-Small Cell Lung CancerOctober 25th, 2017
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
